INHIBRX BIOSCIENCES INC (INBX) Stock Income Statement
NASDAQ:INBX • US45720N1037
Current stock price
58 USD
-7.79 (-11.84%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.30M | 200.00K | 1.80M | 2.19M | 7.23M | |||
| Minority Interest Expense | N/A | N/A | N/A | N/A | N/A | |||
| Operating Expenses | 136.32M | 331.65M | 221.02M | 131.31M | 83.80M | |||
| Research and Development | 110.72M | 201.86M | 190.65M | 109.18M | 70.44M | |||
| Selling, General, and Administrative Expenses | 23.12M | 127.50M | 29.18M | 20.90M | 12.16M | |||
| Operating Income | -135.03M | -331.45M | -219.22M | -129.12M | -76.56M | |||
| Interest Income/Expense | -4.65M | -2.55M | -19.92M | -16.11M | -5.22M | |||
| Other Income/Expense | -381.00K | 75.00K | -580.00K | 0.00 | 10.00K | |||
| Non Recurring Items | 0.00 | 2.02B | N/A | N/A | N/A | |||
| Income Before Taxes | -140.05M | 1.69B | -239.72M | -145.22M | -81.77M | |||
| Income Tax | 2.00K | 2.00K | 3.00K | 0.00 | 0.00 | |||
| Net Income | -140.06M | 1.69B | -241.36M | -145.23M | -81.77M | |||
| EBITDA | -132.54M | -329.16M | -218.03M | -127.89M | -75.36M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -9.04 | 112.62 | -5.12 | -3.62 | -2.15 | |||
| Non GAAP EPS | -9.04 | 118.11 | -5.03 | -3.62 | -2.15 | |||
| Statistics | ||||||||
| Profit Margin | -10773.46% | 843786.00% | -13408.94% | -6631.51% | -1130.98% | |||
| Operating Profit Margin | -10386.54% | -165724.00% | -12178.94% | -5895.89% | -1058.92% | |||
All data in USD